Share Twitter LinkedIn Facebook Email Pedram Razavi, MD, Ph.D. from Memorial Sloan Kettering Cancer Center speaks about SABCS 2021 Presentation – Challenges in early detection – screening and MRD.
FDA Approves Datopotamab Deruxtecan / Datroway from Eli Lilly in Treatment for Unresectable or Metastatic HR-Positive, HER2-Negative Breast Cancer Breast 2 Mins Read
Can Imlunestrant Change the Future of Breast Cancer Treatment? Insights from SABCS with Virginia Kaklamani, MD Breast 3 Mins Read